Irritable bowel syndrome. Irritable bowel syndrome
Conditions
Interventions
Intervention 1: Intervention group: Vitamin B6 (pyridoxine) tablet, 40 mg, every 12 hours for a duration of four weeks. Intervention 2: Control group: Placebo tablet, 40 mg, every 12 hours for a durat
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Newly diagnosed patients with Irritable Bowel Syndrome (IBS) according to the Rome IV criteria Age from 18 to 65 years old
Exclusion criteria
Exclusion criteria: Personal History of malignant diseases of the gastrointestinal tract, Celiac disease, Lactose intolerance, Diverticulitis, Gastrointestinal infection, Hypothyroidism and hyperthyroidism Presence of other diseases during colonoscopy in individuals over 50 years of age Pregnancy and lactation Allergy to the study drug Lack of consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritable bowel syndrome severity. Timepoint: At beginning of the study and four weeks after initiation of the study. Method of measurement: The irritable bowel severity scoring system (IBSSS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life in patients with irritable bowel syndrome. Timepoint: At beginning of the study and four weeks after initiation of the study. Method of measurement: Irritable bowel syndrome quality of life questionnaire (IBS-QOL). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Mahdi Azizian
Islamic Azad University
Outcome results
None listed